📰 Bertram Pitt News
Bertram Pitt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bertram Pitt. Real-time updates on events, politics, business and more.
October 5, 2023
The European Society of Cardiology (ESC) inaugural session unfolded against the backdrop of Amsterdam, the Netherlands...
August 21, 2023
THE WOODLANDS, Texas, Aug. 21, 2023 -- Lexicon Pharmaceuticals, Inc. today announced that analyses of clinical study results relating to INPEFA™ , its recently approved drug for heart...
August 21, 2023
THE WOODLANDS, Texas, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that analyses of clinical study results relating to INPEFA™ (sotagliflozin), its recently approved drug
August 14, 2023
Results show that the new heart failure drug reduces the hospitalizations and risk of death from cardiovascular events.
August 11, 2023
A posthoc analysis of the pivotal SOLOIST-WHF trial provides insight into the effects of sotagliflozin use on risk of cardiovascular mortality and heart failure readmissions at 90 days.
June 14, 2023
Cardiology Today | COVID-19 is predominantly considered an infectious and respiratory disease, but it is intertwined with the CV system as well. That means cardiologists have a lot to contribute to battle it, especially in the area of pathophysiology.Because COVID-19 is often considered an ICU issue and an infectious disease, cardiologists have at times been left on the sideline during the pandemic. But we now know
March 6, 2023
Operator: Good afternoon, and welcome to the Lexicon Pharmaceuticals Fourth Quarter 2022 Earnings Conference Call. All participants will be in a listen-only mode.
January 6, 2023
/PRNewswire/ -- KBP Biosciences PTE. Ltd. ("KBP Biosciences" or the "Company"), a clinical-stage biotechnology company dedicated to research, development, and...
January 6, 2023
Hepatic Impairment and Drug-Drug Interaction Study Results Presented PRINCETON, N.J., Jan. 6, 2023 /PRNewswire/ -- KBP Biosciences PTE. Ltd. ("KBP Biosciences" or the "Company"), a clinical-stage
January 6, 2023
Ocedurenone (KBP-5074) Featured at ASN Kidney Week: Ocedurenone is a Potential New Treatment Option for Patients with Uncontrolled or Resistant Hypertension and Advanced CKD - read this article along with other careers information, tips and advice on BioSpace